New York State Invests Millions in New Biotech Initiative, with Focus on Neurodegenerative Diseases
Overview
New York Governor Kathy Hochul (D) signed the state’s annual budget into law, which includes $65 million for the Governor’s Bolstering Biotech Initiative. This new initiative reflects recommendations developed by the 2025 New York State Emerging Technology Advisory Board (ETAB) — co-chaired by Michael J. Fox Foundation CEO and Co-Founder Debi Brooks — to strengthen New York’s life sciences sector, accelerate the development of new treatments and expand clinical research.
While the initiative is designed to enhance New York’s broader biotechnology ecosystem, it places a particular focus on neurodegenerative diseases, creating new opportunities to advance Parkinson’s research and bring new therapies closer to patients.
In This Article
“As we conclude this effort, I’m more confident than ever in the power of public-private partnership to drive scientific progress. I want to thank Governor Hochul for convening this thoughtful group of leaders who, over several months, have crafted practical and ambitious recommendations to strengthen New York’s biotech ecosystem and accelerate the breakthroughs patients and families urgently deserve.” -Debi Brooks, CEO and co-founder of The Michael J. Fox Foundation
The Big Picture
New York’s approach shows how states can create the conditions needed to develop and deliver promising treatments to people living with diseases like Parkinson’s. MJFF’s Public Policy team works to identify and advocate for opportunities like these in states across the country each year.
